Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway

Yikuan Wu(Jiangnan University), Qixiao Zhai(Jiangnan University)
Acta Pharmacologica Sinica
October 15, 2021
Cited by 57


Related Papers